Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01409590

Enrollment

100

Registered

2011-08-04

Start date

2005-05-31

Completion date

2009-08-31

Last updated

2011-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

Schizophrenia, weight gain, atypical neuroleptics

Brief summary

In this study the investigators will recruit patients with the diagnosis of schizophrenia that are taking atypical neuroleptics and that are willing to participate in an exercise and diet program. The investigators will measure weight and abdomen circumference.

Interventions

BEHAVIORALExercise program

Homogenous exercise program in local fitness centers

BEHAVIORALDiet

Weigh loss diet program prescribed by a professional nutritionist

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 35 Years

Healthy volunteers

Inclusion criteria

* Schizophrenia * Atypical neuroleptics

Exclusion criteria

* Medical illness preventing exercise

Design outcomes

Primary

Measure	Time frame	Description
Weight loss	One year	The weight of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Secondary

Measure	Time frame	Description
Abdomen circumference	One year	The circumference of the abdomen of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026